99 related articles for article (PubMed ID: 21784635)
1. Coordination conjugates of therapeutic proteins with drug carriers: a new approach for versatile advanced drug delivery.
Kejík Z; Bříza T; Králová J; Poučková P; Král A; Martásek P; Král V
Bioorg Med Chem Lett; 2011 Sep; 21(18):5514-20. PubMed ID: 21784635
[TBL] [Abstract][Full Text] [Related]
2. Porphyrin-cyclodextrin conjugates as a nanosystem for versatile drug delivery and multimodal cancer therapy.
Králová J; Kejík Z; Bríza T; Poucková P; Král A; Martásek P; Král V
J Med Chem; 2010 Jan; 53(1):128-38. PubMed ID: 19950899
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.
Li J; Loh XJ
Adv Drug Deliv Rev; 2008 Jun; 60(9):1000-17. PubMed ID: 18413280
[TBL] [Abstract][Full Text] [Related]
4. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate.
Djanashvili K; ten Hagen TL; Blangé R; Schipper D; Peters JA; Koning GA
Bioorg Med Chem; 2011 Feb; 19(3):1123-30. PubMed ID: 20624680
[TBL] [Abstract][Full Text] [Related]
7. Immunotoxins composed of monoclonal antibody to alpha-fetoprotein and gelonin as a potent hepatoma-targeted drug delivery system.
Masuda K; Takahashi K; Nagata S; Hirano K; Takagishi Y
J Drug Target; 1994; 2(4):323-31. PubMed ID: 7532086
[TBL] [Abstract][Full Text] [Related]
8. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
9. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
Sochanik A; Mitrus I; Smolarczyk R; Cichoń T; Snietura M; Czaja M; Szala S
Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
[TBL] [Abstract][Full Text] [Related]
10. Monovinyl sulfone β-cyclodextrin. A flexible drug carrier system.
del Castillo T; Marales-Sanfrutos J; Santoyo-González F; Magez S; Lopez-Jaramillo FJ; Garcia-Salcedo JA
ChemMedChem; 2014 Feb; 9(2):383-9. PubMed ID: 24339407
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
12. Antibody conjugates and therapeutic strategies.
McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ
Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.
Chelvi TP; Jain SK; Ralhan R
Oncol Res; 1995; 7(7-8):393-8. PubMed ID: 8747602
[TBL] [Abstract][Full Text] [Related]
15. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.
Etrych T; Mrkvan T; Ríhová B; Ulbrich K
J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976
[TBL] [Abstract][Full Text] [Related]
16. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
Mura P; Maestrelli F; Cecchi M; Bragagni M; Almeida A
J Microencapsul; 2010; 27(6):479-86. PubMed ID: 20113170
[TBL] [Abstract][Full Text] [Related]
17. Drug-immunoglobulin conjugates as targeted therapeutic systems.
Mitra AK; Ghosh MK
Targeted Diagn Ther; 1990; 3():141-87. PubMed ID: 2131009
[No Abstract] [Full Text] [Related]
18. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
Greco F; Vicent MJ
Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
[TBL] [Abstract][Full Text] [Related]
20. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.
McCormack B; Gregoriadis G
J Drug Target; 1994; 2(5):449-54. PubMed ID: 7704490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
